Neurodiagnostics Market Size & Growth Forecast 2026–2035, By Segments (Technology, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Neurodiagnostics Market size was estimated at USD 18.68 Billion in 2025 and is projected to grow at a 3.9% CAGR from 2026 to 2035, crossing USD 27.39 Billion by 2035. The industry revenue for 2026 is assessed at USD 19.3 billion.
Get more details on this report
Request Free Sample ReportNeurodiagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 37.95% of the market in 2025, supported by advanced diagnostic infrastructure, high procedure volumes, and routine neurological testing across hospitals and specialty care settings.
- Asia Pacific is projected to expand at a 4.45% CAGR as healthcare systems improve neurological care, install more diagnostic equipment, and broaden patient access to specialized testing services.
Segment Momentum
- Neuroimaging Technologies accounted for 60.8% of the market in 2025 because they remain essential for visualizing neurological abnormalities, enabling faster interpretation and supporting routine diagnostic workflows across neurological conditions.
- Imaging Centers are growing fastest due to rising demand for specialized facilities that provide efficient imaging throughput and streamlined access to neurodiagnostic imaging services for patients and healthcare providers.
Market Expansion Drivers
- Rising neurological disorder prevalence increasing demand for advanced brain diagnostic technologies.
- AI-enabled neuroimaging improving diagnostic accuracy and early disease detection capabilities.
- Expanding geriatric population driving higher incidence of Alzheimer’s and Parkinson’s disease diagnostics.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent players in the neurodiagnostics market include Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Canon Medical Systems Corporation (Japan), Nihon Kohden Corporation (Japan), Natus Medical Incorporated (United States), Compumedics Limited (Australia), Cadwell Industries, Inc. (United States), Advanced Brain Monitoring, Inc. (United States), FUJIFILM Holdings Corporation (Japan).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As the burden of conditions such as epilepsy, stroke, multiple sclerosis, and neurodegenerative disorders rises, care pathways increasingly depend on earlier and more precise assessment of brain function and structure, increasing demand for the neurodiagnostics market. Hospitals and specialty neurology centers are expanding use of EEG, MRI, CT, PET, and related diagnostic platforms because growing patient volumes make symptom-based evaluation less sufficient, especially when treatment decisions depend on differentiating overlapping neurological presentations. This trend is aiding market expansion by increasing test utilization, encouraging investment in higher-resolution and multimodal systems, and pushing providers to strengthen diagnostic capacity for faster triage and more confident clinical decision-making.
AI-enabled neuroimaging improving diagnostic accuracy and early disease detection capabilities
AI integration is changing how imaging data is interpreted, making the neurodiagnostics market more valuable to providers seeking faster and more consistent identification of subtle neurological abnormalities. In practice, AI-enabled neuroimaging tools help radiologists and neurologists detect patterns associated with early-stage neurodegeneration, cerebrovascular events, and lesion progression that may be difficult to assess through conventional review alone. That improvement in workflow efficiency and diagnostic confidence is influencing market adoption by supporting broader deployment of advanced imaging software, increasing the clinical utility of existing imaging infrastructure, and reinforcing demand for platforms that combine acquisition, analysis, and decision support in a single neurodiagnostic workflow.
Expanding geriatric population driving higher incidence of Alzheimer’s and Parkinson’s disease diagnostics
Population aging is steadily increasing the number of patients presenting with cognitive decline, movement disorders, and other age-associated neurological symptoms, creating sustained demand for the neurodiagnostics market. Clinicians are relying more heavily on brain imaging, electrophysiological testing, and biomarker-linked diagnostic approaches to distinguish Alzheimer’s disease, Parkinson’s disease, and related disorders from other causes of memory loss or motor impairment. This is contributing to market size growth by raising screening and follow-up volumes, while also encouraging healthcare systems to invest in diagnostic capabilities that support earlier intervention, longitudinal monitoring, and more structured management of chronic neurodegenerative disease.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising neurological disorder prevalence increasing demand for advanced brain diagnostic technologies | 2.30% | High | North America, Europe, Asia Pacific | High | Near Term |
| AI-enabled neuroimaging improving diagnostic accuracy and early disease detection capabilities | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Expanding geriatric population driving higher incidence of Alzheimer’s and Parkinson’s disease diagnostics | 1.70% | High | Global | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional position in 2025, accounting for a 37.95% share of the neurodiagnostics market. This leadership is underpinned by the region’s established diagnostic infrastructure, broad availability of advanced imaging and monitoring systems, and routine integration of neurological testing into hospital and specialty care workflows. In practice, higher procedure volumes, earlier access to new diagnostic technologies, and stronger concentration of specialized providers help maintain consistent demand across clinical settings where neurological disorders require timely and accurate evaluation.
Asia Pacific is projected to expand at a 4.45% CAGR over the forecast period in the neurodiagnostics market, bolstered by rising access to neurological care and increasing adoption of diagnostic technologies across developing healthcare systems. Growth is being fueled by the practical expansion of hospital capacity, wider installation of diagnostic equipment, and improving clinical attention to conditions that require electrophysiological and imaging-based assessment. As healthcare delivery becomes more capable of supporting specialized testing, regional uptake is accelerating through broader patient access and a growing base of treatment centers equipped to perform neurodiagnostic procedures.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Neurology FocusGermany is strengthening neurodiagnostic capabilities through advanced imaging and electrophysiological testing across specialized neurological centers. German healthcare institutions are prioritizing standardized diagnostic pathways that support accurate evaluation of complex neurological conditions.
France 🇫🇷
Integrated Neurology NetworksFrance is reinforcing coordinated neurodiagnostic services across hospitals and specialized neurological centers. French healthcare providers are focusing on efficient diagnostic pathways that support timely intervention for epilepsy, stroke, and neurodegenerative disorders.
Italy 🇮🇹
Hospital Diagnostic ModernizationItaly is modernizing neurodiagnostic infrastructure to improve access to advanced neurological assessments across regional healthcare systems. Italian hospitals are upgrading diagnostic equipment while expanding specialist capabilities for comprehensive neurological evaluation.
Japan 🇯🇵
Neuro Aging AssessmentJapan is expanding neurodiagnostic services to address growing demand associated with age-related neurological disorders. Healthcare providers in Japan are emphasizing early diagnosis and continuous monitoring supported by highly reliable diagnostic technologies.
South Korea 🇰🇷
AI-Enabled DiagnosticsSouth Korea is incorporating artificial intelligence into neurodiagnostic workflows to improve interpretation speed and diagnostic consistency. Hospitals across South Korea are investing in connected diagnostic platforms that strengthen neurological care delivery.
United States 🇺🇸
Advanced Diagnostic AdoptionThe U.S. continues investing in sophisticated neurodiagnostic technologies that support earlier detection of neurological disorders. Healthcare providers are integrating multimodal diagnostic platforms with digital workflows to improve clinical efficiency and patient management.
Segment Leadership and Growth Trends
Neurodiagnostics Market Share (%), Technology, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportNeuroimaging Technologies held the leading position in the neurodiagnostics market in 2025, accounting for a 60.8% share. This leadership is maintained through the central role of imaging in identifying structural and functional neurological abnormalities during routine clinical evaluation. In the neurodiagnostics market, neuroimaging technologies remain deeply embedded in frontline diagnostic workflows because they support direct visualization, faster clinical interpretation, and broad applicability across a wide range of neurological conditions.
In Vitro Diagnostics is emerging as the fastest-growing technology area in the neurodiagnostics market as clinical practice places greater emphasis on test methods that can support earlier and more targeted neurological assessment. Its momentum is tied to the practical need for scalable and less procedure-intensive diagnostic support, especially where clinicians seek complementary evidence beyond imaging. Compared with established imaging-led pathways, in vitro diagnostics is experiencing stronger uptake through its ability to fit evolving diagnostic workflows that increasingly value accessible and biologically informed evaluation.
End Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Imaging Centers (Fastest-Growing Segment)
By 2025, Hospitals & Clinics represented the largest end-use segment in the neurodiagnostics market with a 44.84% share. Their leading share reflects the concentration of neurological diagnosis within integrated care settings where patient evaluation, specialist consultation, imaging access, and follow-up management are handled in one place. In the neurodiagnostics market, hospitals and clinics maintain this position because they are the primary point of care for patients presenting with complex neurological symptoms that require coordinated diagnostic decision-making.
Imaging Centers are the fastest-growing end-use segment in the neurodiagnostics market, encouraged by rising demand for dedicated diagnostic environments built around efficient imaging throughput. Their growth is underpinned by the practical advantage of focused imaging operations, which align well with increasing use of scan-based neurological assessment. Relative to broader care settings, imaging centers are gaining momentum as providers and patients increasingly rely on specialized facilities that can streamline access to neurodiagnostic imaging services.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Technology | Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics | Neuroimaging Technologies | In Vitro Diagnostics |
| End Use | Hospitals & Clinics, Diagnostic Laboratories, Imaging Centers, Others | Hospitals & Clinics | Imaging Centers |
Competitive Landscape and Market Positioning
1. Siemens Healthineers AG (Germany)
2. Koninklijke Philips N.V. (Netherlands)
3. GE HealthCare Technologies Inc. (United States)
4. Canon Medical Systems Corporation (Japan)
5. Nihon Kohden Corporation (Japan)
6. Natus Medical Incorporated (United States)
7. Compumedics Limited (Australia)
8. Cadwell Industries Inc. (United States)
9. Advanced Brain Monitoring Inc. (United States)
10. FUJIFILM Holdings Corporation (Japan)
Diagnostic intelligence systems are becoming more deeply embedded in neurological assessment workflows, enabling higher precision in detecting and analyzing brain-related disorders. Continuous advancements in analytical modeling and imaging integration are improving diagnostic speed and accuracy across clinical environments. The neurodiagnostics market is evolving through innovation in data-driven tools that enhance early detection capabilities and support more personalized neurological care pathways.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cadwell; Medical Informatics Corp | Dec-25 | Cadwell and Medical Informatics Corp formed a strategic partnership to integrate neurodiagnostic systems with the Sickbay Clinical Platform, enabling unified multimodal hospital data architecture. The collaboration establishes integrated clinical intelligence across neurodiagnostic devices, improving data interoperability and supporting advanced monitoring capabilities beyond traditional device-centric workflows. |
| EBRAINS | Jan-26 | EBRAINS became an associate partner in the European Partnership for Brain Health, a ten-year initiative valued at approximately USD 589.74 million involving over 55 institutions. The collaboration strengthens digital research infrastructure capabilities and supports coordinated advancement in neurological and mental health research across Europe. |
| Philips; SyntheticMR | Mar-24 | Philips partnered with SyntheticMR to introduce an AI-based quantitative brain imaging system aimed at improving detection and analysis of neurological conditions including multiple sclerosis, traumatic brain injury, and dementia. The solution enhances diagnostic precision through automated quantitative MRI processing. |
| Neurophet | Mar-24 | Neurophet launched AI-powered brain imaging analysis technology at AD/PD 2024, designed to assess brain atrophy and white matter hyperintensities in MRI scans. The solution supports improved diagnostic evaluation for Alzheimer’s disease and other neurodegenerative conditions through advanced image analytics. |
| Philips | Feb-24 | Philips launched the Azurion neuro biplane system at ECR 2024 to enhance minimally invasive neurovascular diagnosis and treatment. The system improves procedural speed and imaging precision, supporting expanded adoption of advanced interventional neurodiagnostic and treatment workflows in clinical settings. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Neurodiagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Neurodiagnostics Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of neurodiagnostics?
How much is the neurodiagnostics industry expected to grow by 2035?
How is rising neurological disorder prevalence impacting demand in the neurodiagnostics market?
How is AI-enabled imaging and aging populations reshaping diagnostic approaches in the neurodiagnostics market?
Why do Neuroimaging Technologies lead the neurodiagnostics market?
Why are Imaging Centers the fastest-growing end-use segment in the neurodiagnostics market?
Why is North America the leading neurodiagnostics market?
What is accelerating neurodiagnostics market growth in Asia Pacific?
Which companies dominate the neurodiagnostics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization